OLYMPUS UM-2R/3R ULTRASONIC PROBES AND ASSOCIATED ANCILLARY EQUIPMENT (URINARY TRACT)
Device Facts
| Record ID | K982610 |
|---|---|
| Device Name | OLYMPUS UM-2R/3R ULTRASONIC PROBES AND ASSOCIATED ANCILLARY EQUIPMENT (URINARY TRACT) |
| Applicant | Olympus Optical, Co. |
| Product Code | ITX · Radiology |
| Decision Date | Nov 16, 1998 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1570 |
| Device Class | Class 2 |
Indications for Use
The Olympus UM-2R and UM-3R Ultrasonic Probes have been designed for use in combination with Olympus Endoscopic Ultrasound System for intraluminal sonographic imaging of the urinary tract.
Device Story
The UM-2R and UM-3R are ultrasonic probes designed for transendoscopic access to the urinary tract. Used in conjunction with a therapeutic urethro-cystoscope (minimum 9Fr capacity) and an Olympus Endoscopic Ultrasound System (EU-M30, EU-M20, or EU-M3), the probes provide B-mode, 360-degree mechanical/radial scanning of tissue. A probe-driving unit controls transducer rotation. The 2.4 mm diameter insertion tube allows navigation through strictures and anatomical ducts. The UM-2R operates at 12 MHz; the UM-3R operates at 20 MHz. Physicians use the resulting B-mode images for intensive examination and diagnosis of the urinary tract. The device is marketed non-sterile and requires reprocessing. Benefits include improved access to areas of interest within the urinary tract compared to conventional urethro-cystoscopes.
Clinical Evidence
Bench testing only. The device complies with IEC 60601-1 and FDA's 1993/1985 Diagnostic Ultrasound Guidance. No clinical data provided.
Technological Characteristics
Mechanical/radial scanning transducer; 12 MHz (UM-2R) or 20 MHz (UM-3R) operating frequency; 2.4 mm outer diameter; 2050 mm length; B-mode imaging; de-aerated water immersion method; compatible with Olympus EU-M30, EU-M20, and EU-M3 systems; non-sterile; reprocessable.
Indications for Use
Indicated for intraluminal sonographic imaging of the urinary tract in patients requiring intensive examination, observation, and diagnosis of the urinary tract.
Regulatory Classification
Identification
A diagnostic ultrasonic transducer is a device made of a piezoelectric material that converts electrical signals into acoustic signals and acoustic signals into electrical signals and intended for use in diagnostic ultrasonic medical devices. Accessories of this generic type of device may include transmission media for acoustically coupling the transducer to the body surface, such as acoustic gel, paste, or a flexible fluid container.
Predicate Devices
- Olympus EU-M30 (K951994)
- Olympus UM-2R / UM-3R (K944610)
- Olympus EU-M20 (K926514)
- Olympus EU-M3 (K882061)
Submission Summary (Full Text)
{0}------------------------------------------------
NOV 16 1998
K982610
### 510(k) SUMMARY OLYMPUS UM-2R/UM-3R ULTRASONIC PROBE
| Device Name: | Olympus UM-2R / UM-3R Ultrasonic Probes<br>and its ancillary equipment for urinary tract |
|-------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|
| Common / Usual Name: | Olympus Ultrasonic Probes |
| Classification Number<br>& Classification Name: | Class II , 21CFR 892.1570<br>Diagnostic ultrasound transducer<br>Class II, 21CFR876.1500<br>Endoscope and accessories |
| Predicate Devices: | Olympus EU-M30 (K951994)<br>Olympus UM-2R / UM-3R (K944610)<br>Olympus EU-M20 (K926514)<br>Olympus EU-M3 (K882061) |
| Submitted By:<br>(Contact Person) | Laura Storms-Tyler<br>Olympus America Inc.<br>Regulatory Affairs<br>Two Corporate Center Drive<br>Melville, NY 11747<br>(516) 844-5688 |
| Summary Preparation Date: | July 23, 1998 |
### Statement of Intended Use
The Olympus UM-2R and UM-3R Ultrasonic Probes have been cleared for use within the gastrointestinal tract in 510(k) #K944610.
The Olympus UM-2R and UM-3R Ultrasonic Probes have been designed for use in combination with Olympus Endoscopic Ultrasound System for intraluminal sonographic imaging of the urinary tract.
### Device Description
In routine examination of the urinary tract, there are situations where the physician prefers to perform an intensive examination, observation, and diagnosis of the urinary tract. The ponventional type therapeutic urethro-cystoscope limits the physician's ability to access certain areas of interest. The UM-2R / UM-3R Ultrasonic Probes, when used with an endoscope offer transendoscopic access to the urinary tract. The 2.4 mm insertion tube of these probes
{1}------------------------------------------------
can be advanced through strictures and anatomical ducts. The Olympus Ultrasonic Probes to be used in conjunction with therapeutic urethro-cystoscope with a minimum capacity size of 9Fr.. A probe-driving unit controls the rotation of the transducer.
The UM-2R and UM-3R probes produce a B-mode scans using the de-aerated water immersion method and offer 360 degree mechanical/radial scanning of the tissue under observation. The outer diameter of the insertion tube is 2.4 mm and the length is 2050 mm. Both probes incorporate similar design, construction, intended use, and method of operation. The only difference between these two probes is that the UM-2R probe operates at 12 MHz and is compatible with both Olympus EU-M30, EU-M20 and EU-M3 Endoscopic Ultrasound Systems, while the UM-3R probe operates at 20 MHz and is compatible with the EU-M30 and the EU-M20 Endoscopic Ultrasound System. The Olympus EU-M30 Endoscopic Ultrasound Center was cleared for marketing in 510(k) # K951994. The Olympus EU-M20 Endoscopic Ultrasound System was cleared for marketing in 510(k) # K926514 and EU-M3 Endoscopic Ultrasound System was cleared for marketing in the 510(k) # K882061.
All components and associated equipment of the UM-2R / UM-3R Ultrasonic Probes will be marketed non-sterile and can be reprocessed as described in the Instruction Manual.
### Safety
The Olympus UM-2R and UM-3R Ultrasound Probes are designed, manufactured, and tested in compliance with International Standard IEC 60601-1. The ultrasound characteristics of Olympus UM-2R and UM-3R Ultrasound Probes meet the requirements of the FDA's 510(k) Diagnostic Ultrasound Guidance for 1993 and 1985.
When compared to the predicate devices listed in the "Regulatory History" portion of this section, except for intended use, neither ultrasound probe incorporates any significant change in method of operation, material, or design that could affect safety or effectiveness.
{2}------------------------------------------------
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol of medicine, with three figures in profile facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the caduceus.
NOV 16 199
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Laura Storms-Tyler Director, Regulatory Affairs Olympus Optical Co., Ltd. C/O Olympus America 2 Corporate Center Melville, New York 11747
K982610 Re: Olympus UM-2R/3R Ultrasonic Probes Dated: October 22, 1998 Received: October 27, 1998 Requlatory class: II 21 CFR 892.1570/Procode: 90 ITX
Dear Mr. Storms-Tyler:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for urinary test use with the Olympus EU-M30, EU-M20 and EU-M3 Endoscopic Ultrasound Systems, as described in your premarket notification:
Transducer Model Number
UM-2R (12 MHz) UM-3R (20 MHz)
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic QS inspections, the FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you may have under sections 531 and 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{3}------------------------------------------------
Page - 2 - Ms. Storms-Tyler
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. Tt should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
> Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Other general information on your responsibilities under the Act may 807.97). be obtained from the Division of Small Manufacturers Assistance at its tollfree number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
If you have any questions regarding the content of this letter, please contact Rod Perez at (301) 594-1212.
Sincerely yours,
David A. Szymon
Lillian Yin, Ph.D.
rector, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K982610
Appendix F
### Diagnostic Ultrasound Indications for Use Form
## Fill out one form for each ultrasound system and each transducer.
Int inded Use: Diagnostic uttrasound imaging or fluid flow analysis of the human body as follows:
| Mode of Operation | | | | | | | | | | |
|----------------------------------|---|---|-----|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------|
| Cli ical Application | A | B | M | PWD | CWD | Color<br>Doppler | Amplitude<br>Doppler | Color<br>Velocity<br>Imaging | Combined<br>(specify) | Other<br>(specify) |
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative (specify) | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ (specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Transesophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal<br>Conventional | | | | | | | | | | |
| Musculo-skeletal Superficial | | | | | | | | | | |
| Other (specify) | | | N/P | | | | | | | |
Ultrasound System: EU-M3
ખ્ય
A-new.Indication: P-previously cleared by FDA; E-added under Appendix E
A Iditional Comments:
New indications=Intraluminal ultrasound for urinary tract.
Previously cleared indications=Intraluminal ultrasound for
gastrointestinal tract.
In LINE - OONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evals
David A. Segner
(Division Sign-Off)
તું નુ
510(k) Number
Division of Reproductive, Abdominal, ENT and Radiological Dev
Frescription Use (Per 21 CFR 801.109)
{5}------------------------------------------------
## Diagnostic Ultrasound Indications for Use Form
# fill out one form for each ultrasound system and each transducer.
In anded Use: Diagnostic uttrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | A | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (specify) | Other (specify) | |
|------------------------------|---|---|---|-----|-----|---------------|-------------------|------------------------|--------------------|-----------------|--|
| Ophthalmic | | | | | | | | | | | |
| Fe | | | | | | | | | | | |
| At: lominal | | | | | | | | | | | |
| Int soperative (specify) | | | | | | | | | | | |
| Ini soperative Neurologloul | | | | | | | | | | | |
| Pelletric | | | | | | | | | | | |
| Srell Organ (specify) | | | | | | | | | | | |
| Ne natal Caphallo | | | | | | | | | | | |
| Ac #Cephalic | | | | | | | | | | | |
| Ca diac | | | | | | | | | | | |
| Tr neesophageal | | | | | | | | | | | |
| To norectal | | | | | | | | | | | |
| Ti nsvaginal | | | | | | | | | | | |
| Ti nourethml | | | | | | | | | | | |
| In avesculer | | | | | | | | | | | |
| P. spharal Vascular | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| V. aculo-skaletai | | | | | | | | | | | |
| C. nventional | | | | | | | | | | | |
| Musculo-skeletal Superficiel | | | | | | | | | | | |
| Other (specify) | | N | / | P | | | | | | | |
N = new Indication; P= previously cleared by FDA; E= added under Appendix E
A Iditional Comments:
New indications-Intraluminal ultrasound for urinary tract.
Previously cleared indications=Intraluminal ultrasound for
gastrointestinal tract.
(PLEASE DO NOT WRITE BELOW THIS LINE - DONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
F-3
l rescription Use (Per 21 CFR 801.109)
Ultrasound System: EU-M30
.
Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number _ 4011
(Division Sign-Off) 1
{6}------------------------------------------------
#### Appendix F
### Diagnostic Ultrasound Indications for Use Form
## Fill out one form for each ultrasound system and each transducer.
Int inded Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| | A | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (specify) | Other (specify) |
|-------------------------------|-------------------|-----|---|-----|-----|---------------|-------------------|------------------------|--------------------|-----------------|
| Clinical Application | Mode of Operation | | | | | | | | | |
| Ophthalmic | | | | | | | | | | |
| Fe I | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Int soperative (specify) | | | | | | | | | | |
| Int soperative Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ (specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Transesophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional | | | | | | | | | | |
| Musculo-skeletal Superficial | | | | | | | | | | |
| Other (specify) | | N/P | | | | | | | | |
\ = new .Indication; P= previously cleared by FDA; E= added under Appendix E
#### A Iditional Comments:
New indications=Intraluminal ultrasound for urinary tract.
Previously cleared indications=Intraluminal ultrasound for
gastrointestinal tract.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Hoganson
(Division Sign-Off)
દુર
I rescription Use (Per 21 CFR 801.109)
Division of Reproductive, Abdominal, ENT, E-3 and Radiological Devices 510(k) Number
Ultrasound System: EU-M20
{7}------------------------------------------------
## Diagnostic Ultrasound Indications for Use Form
#
Fill out blief of the form for and imaging or fluid flow analysis of the human body as follows:
Internetic use: Diagnostic ultrasound Imaging or fluid flow analysis of the hu
| Cli ical Application | A | B | M | PWD | CWD | Color<br>Doppler | Amplitude<br>Doppler | Color<br>Velocity<br>Imaging | Combined<br>(specify) | Other<br>(specify) | |
|-----------------------------------------------------------------------------|---|-----|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------|--|
| Ophthalmic | | | | | | | | | | | |
| Fe al | | | | | | | | | | | |
| At: tominal | | | | | | | | | | | |
| Int ioperative (specify) | | | | | | | | | | | |
| Int-operative Neurological | | | | | | | | | | | |
| Pe iatric | | | | | | | | | | | |
| Small Organ (specify) | | | | | | | | | | | |
| Ne natal Cephalic | | | | | | | | | | | |
| Ac Cephalic | | | | | | | | | | | |
| Or theo | | | | | | | | | | | |
| Ti essophageal | | | | | | | | | | | |
| Ti norectal | | | | | | | | | | | |
| Ti asvaginal | | | | | | | | | | | |
| Th nourethral | | | | | | | | | | | |
| In avascular | | | | | | | | | | | |
| P-Aphecal Vascular | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| M usculo-skeletal | | | | | | | | | | | |
| C ventioned | | | | | | | | | | | |
| Musculo-skeletal Superficial | | | | | | | | | | | |
| Other (specify) | | N/P | | | | | | | | | |
| Mode of Operation | | | | | | | | | | | |
| Cll ical Application | A | B | M | PWD | CWD | Color<br>Doppler | Amplitude<br>Doppler | Color<br>Velocity<br>Imaging | Combined<br>(specify) | Other<br>(specify) | |
| Ophthalmic | | | | | | | | | | | |
| Fe & | | | | | | | | | | | |
| Abdominal | | | | | | | | | | | |
| Intraoperative (specify) | | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | | |
| Pelvic | | | | | | | | | | | |
| Small Organ (specify) | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult & Cephalic | | | | | | | | | | | |
| Cardiac | | | | | | | | | | | |
| Transesophageal | | | | | | | | | | | |
| Transrectal | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| Musculo-skeletal | | | | | | | | | | | |
| Conventional | | | | | | | | | | | |
| Musculo-skeletal Superficial | | | | | | | | | | | |
| Other (specify) | | N/P | | | | | | | | | |
| N = new Indication; P= previously cleared by FDA; E= added under Appendix E | | | | | | | | | | | |
| Additional Comments: | | | | | | | | | | | |
| New indications-Intraluminal ultrasound for urinary tract. | | | | | | | | | | | |
It on another Page of needed. o of CDHH, Oillos of Device Evaluation (ODE)
l · rescription Use (Per 21 CFR 801.109)
David A. Tyson
F(Division Sign-Off)
( Division of Reproductive, Abdominal, ENT, and Radiological D 510(k) Number
Transducer
12 MHz Catalog #27023 Model UM2R
ven
{8}------------------------------------------------
# Diagnostic Ultrasound Indications for Use Form
# Diagnosus Claim for each ultrasound system and each transducer.
Fill out one form for each ultrasound system in the lower bedress
In anded Use: Diagnostic utrasound imaging or fluid flow analysis of the human boty as follows:
In inded Use: Diagnostic ultrasound imaging or fluid flow analysis of the huma
Transducer
20 MHz Catalog # 27024 Mode1 UM3R
જીન્દ્ર
DELOW THIS LINE - DON'THOUR ON AND THEIR PAGE IF NEEDED on of CDFH, Office of Device Evaluation (ODE)
l rescription Use (Per 21 CFR 801.109)
gastrointestinal tract.
F-3
(Division Sign-Off)
Division of Res
પ્રદૂધની વસ્તર પ્રદૂષ
(Division of Reproductive, Abdominal
Division of Reproductive, Abdominal, ENT.
Score, recoloron of Reproduction and Radiological Dep
510(k) Number K962610
